MMS

Name: MMS
Address: 6880 Commerce Boulevard, Canton, MI, 48187, US
Telephone: +17342450310
Price range: Not applicable

MMS is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach.

MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet

rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company has been recognized as a leading CRO in Global Health & Pharma’s international awards programs for three consecutive years.

06/02/2026

Navigating the European regulatory landscape requires more than compliance, it requires staying ahead of change.

In this short video, Sharon Morton, Principal Regulatory Strategist at MMS, shares practical insight from 30 years of supporting global sponsors across development, submissions, and lifecycle management.

At MMS, our European teams support sponsors with both strategic guidance and practical ex*****on, across projects of all sizes.

Learn more about our work in Europe: https://hubs.li/Q04jJP490

06/01/2026

MMS is growing and so is our team!

Across our global team, we’re adding new roles to support the increasing demand for data-driven clinical and regulatory expertise. If you’re looking to be part of a collaborative, science-led CRO, explore our latest opportunities:
- Senior Biostatistician (US & UK)
- CSR Narrative Writer (Malaysia & Philippines)
- Project Manager (UK)
- Study Design Statistician (UK & US)
- Senior Medical Writer (US)

Join a team focused on delivering practical, credible solutions that advance clinical development: https://hubs.li/Q04jzxSk0

05/28/2026

Today at 11am EST, Ben Kaspar, Vice President of Regulatory Strategy, and Lucy Sutton, Vice President of Account Management, will get together for a fireside chat webinar to share real world examples of how AI is supporting regulatory workflows, from improving content consistency to helping teams get submission-ready faster, without compromising quality or compliance.

Last chance to register: https://hubs.li/Q04hT0x70

05/27/2026

As part of our 20‑year anniversary celebrations, we were delighted to bring the MMS team together in Belfast for a special evening with our colleagues.

This milestone was about the people behind the work, the relationships, shared values, and global collaboration that have shaped MMS over the past two decades. We were proud to celebrate this moment with the teams who continue to make it possible.

Here’s to 20 years of partnership, progress, and the MMS community.

Click here to learn more about our journey to 20-years of success: https://hubs.li/Q04hVkCR0

05/26/2026

Connect with us in Boston for an in-person RAPS Boston Chapter event focused on the realities of regulatory leadership, from early development through commercialization.

Join Aiden Flynn, Senior Vice President of Strategic Statistical Services, Ben Kaspar, Vice President of Regulatory Strategy, and April Nguyen, Associate Director of Regulatory Strategy, for a panel: From Molecule to Market—Regulatory Leadership at Biogen.

If you’re in the Boston area, it’s a great opportunity to connect and exchange insights with peers.

Register via the QR code in the image: https://hubs.li/Q04hSKXx0

05/25/2026

Expedited pathways can accelerate development, but only with the right strategy.
Our eBook, A Practical Guide to Expedited Regulatory Pathways, offers direction on selecting the right pathways, engaging regulators early, and advancing therapies with confidence, without compromising scientific rigor.

Download the free eBook: https://hubs.li/Q04hMtSc0

05/22/2026

How is AI actually being applied in regulatory submissions today, and where is it delivering real value?

Join our webinar on May 28 at 11am EST to explore practical, real-world use cases for AI in regulatory operations. Ben Kaspar, Vice President of Regulatory Strategy, and Lucy Sutton, Vice President of Account Management, will discuss how teams are using AI to support submission readiness, improve content consistency, and reduce timelines, while maintaining quality and regulatory confidence.

Register today: https://hubs.li/Q04hDPDC0

05/21/2026

We’re pleased to be collaborating with RAPS on an upcoming 2026 chapter event, bringing together regulatory professionals to share practical perspectives on today’s evolving landscape.

This in‑person session will take place at Ketryx in Cambridge, MA and will feature a panel discussion with MMS’ Aiden Flynn, Senior Vice President of Strategic Statistical Consulting, and Ben Kaspar, Vice President of Regulatory Strategy, exploring how aligned regulatory and statistical strategy can support more effective clinical development decisions.

Register via the event link or QR code: https://hubs.li/Q04hwfGf0

05/20/2026

Today, on International Clinical Trials Day, we celebrate the progress being made across clinical research and the impact it has on patients around the world.

Behind every clinical trial is a shared goal: generating high-quality evidence that can lead to safer, more effective therapies and better outcomes. At MMS, our focus has always been on supporting that goal, helping sponsors navigate complex trials with the scientific, regulatory, and data expertise needed to improve decision-making and maintain confidence in the evidence being generated.

As trials continue to evolve, so does the responsibility to ensure they are designed and delivered in ways that ultimately benefit the patients they aim to serve.

05/19/2026

Real-world evidence is only as strong as the methods behind it.

As RWD becomes more central to clinical development, the challenge lies in ensuring data can support regulatory and clinical decisions.

Our latest blog explores how a rigorous data science approach, grounded in integration, robust analytics, and transparent governance, turns complex real-world data into reliable insight.

Read more: https://hubs.li/Q04h5QNv0

Address

6880 Commerce Boulevard
Canton, MI
48187

Telephone

+17342450310

Website

http://www.mmsholdings.com/

Alerts

Be the first to know and let us send you an email when MMS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Engineering Company in Canton?

MMS